tiprankstipranks
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
US Market

Cardiff Oncology (CRDF) Income Statement

Compare
1,676 Followers

Cardiff Oncology Income Statement

Last quarter (Q4 2024), Cardiff Oncology's total revenue was $151.00K, a decrease of -3.21% from the same quarter last year. In Q4, Cardiff Oncology's net income was $-11.79M. See Cardiff Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 683.00K$ 488.00K$ 386.00K$ 359.00K$ 365.99K
Gross Profit
$ 683.00K$ 488.00K$ 186.00K$ -141.00K$ -10.87M
Operating Expenses
$ 49.33M$ 45.90M$ 40.29M$ 29.21M$ 19.45M
Depreciation and Amortization
$ 0.00$ 398.00K$ 200.00K$ 500.00K$ 466.01K
EBITDA
$ -48.65M$ -45.01M$ -39.67M$ -28.40M$ -18.84M
Operating Income
$ -48.65M$ -45.41M$ -39.90M$ -28.86M$ -19.09M
Other Income/Expenses
$ 3.20M$ 3.97M$ 1.20M$ 564.00K$ -220.67K
Pretax Income
$ -45.45M$ -41.44M$ -38.70M$ -28.29M$ -19.31M
Net Income
$ -45.45M$ -41.44M$ -37.51M$ -27.74M$ -19.28M
Per Share Metrics
Basic EPS
$ -0.95$ -0.93$ -0.86$ -0.71$ -0.92
Diluted EPS
$ -0.95$ -0.93$ -0.86$ -0.71$ -0.92
Weighted Average Shares Outstanding
47.65M 44.68M 43.60M 39.03M 20.87M
Weighted Average Shares Outstanding (Diluted)
47.65M 44.68M 43.60M 39.03M 20.87M
Currency in USD

Cardiff Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis